H

Hana Pharm Co Ltd
KRX:293480

Watchlist Manager
Hana Pharm Co Ltd
KRX:293480
Watchlist
Price: 10 380 KRW -0.1% Market Closed
Market Cap: 184.5B KRW

Hana Pharm Co Ltd
Investor Relations

Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.

Show more
Loading

Earnings Calls

No Earnings Calls Available

Management

Taehong Choi
Pres, CEO & Director
No Bio Available
Hong-Joo Yun
Director of Bus. Department, CFO & Director
No Bio Available
Elia Cho
Director of Global Department & Director
No Bio Available

Contacts

Address
GYEONGGI-DO
Hwaseong
13-39, Jeyakdanji-ro, Hyangnam-eup
Contacts
+82313665511
www.hanaph.co.kr